Acceleron Pharma's CMO resigns despite company claims of a strong outlook for a cancer wonder drug.
Oramed's research team developed a pill that can introduce insulin to the body without breaking down from the different enzymes of the gastrointestinal tract.
Saudi Arabia's mega-city project hopes to be an alternative booster to its oil-dependent economy.
Kiran Mazumdar-Shaw's her leadership shines in biotechnology among other things.
Hemogenyx's innovative and revolutionary products can keep investors' eyes on the company.
Innovations in the industry are enticing investors to buy biotech stocks.
It’s a billion-dollar biotech based out of California, and it has a host of late stage assets that are, assuming things run smoothly, poised to hit...
Investing in biotech stocks can be risky as the industry is known for its inconsistency, so investors studied the stocks more carefully before buying.